Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.6.4.4 (
kinesin
)
5,033
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Several lines of evidence indicate that alterations in axonal transport play a critical role in Alzheimer's disease (AD) neuropathology, but the molecular mechanisms that control this process are not understood fully. Recent work indicates that
presenilin 1
(
PS1
) interacts with glycogen synthase kinase 3beta (GSK3beta). In vivo, GSK3beta phosphorylates
kinesin
light chains (KLC) and causes the release of
kinesin
-I from membrane-bound organelles (MBOs), leading to a reduction in
kinesin
-I driven motility (Morfini et al., 2002b). To characterize a potential role for
PS1
in the regulation of
kinesin
-based axonal transport, we used
PS1
-/- and
PS1
knock-inM146V (KIM146V) mice and cultured cells. We show that relative levels of GSK3beta activity were increased in cells either in the presence of mutant
PS1
or in the absence of
PS1
(
PS1
-/-). Concomitant with increased GSK3beta activity, relative levels of KLC phosphorylation were increased, and the amount of
kinesin
-I bound to MBOs was reduced. Consistent with a deficit in
kinesin
-I-mediated fast axonal transport, densities of synaptophysin- and syntaxin-I-containing vesicles and mitochondria were reduced in neuritic processes of KIM146V hippocampal neurons. Similarly, we found reduced levels of
PS1
, amyloid precursor protein, and synaptophysin in sciatic nerves of KIM146V mice. Thus
PS1
appears to modulate GSK3beta activity and the release of
kinesin
-I from MBOs at sites of vesicle delivery and membrane insertion. These findings suggest that mutations in
PS1
may compromise neuronal function by affecting GSK-3 activity and
kinesin
-I-based motility.
...
PMID:Alzheimer's presenilin 1 mutations impair kinesin-based axonal transport. 1280 90
The ciliary rootlet is a large striated fibrous network originating from basal bodies in ciliated cells. To explore its postulated role in intracellular transport, we investigated the interaction between
kinesin
light chains (KLCs) and rootletin, the structural component of ciliary rootlets. We show here that KLCs directly interact with rootletin and are located along ciliary rootlets. Their interactions are mediated by the heptad repeats of KLCs. Further studies found that these interactions tethered
kinesin
heavy chains along ciliary rootlets. However, the ciliary rootlet-bound
kinesin
-1 did not recruit microtubules or move along ciliary rootlets. Additionally, amyloid precursor protein (APP; a
kinesin
-1 vesicular cargo receptor) and
presenilin 1
(a presumed cargo of APP/
kinesin
-1) were found to be enriched along the rootletin fibers, suggesting that the interaction between ciliary rootlets and
kinesin
-1 recruits APP and
presenilin 1
along ciliary rootlets. These findings indicate that ciliary rootlets may provide a scaffold for
kinesin
-1 vesicular cargos and, thus, play a role in the intracellular transport in ciliated cells.
...
PMID:The ciliary rootlet interacts with kinesin light chains and may provide a scaffold for kinesin-1 vesicular cargos. 1601 97
Alcadeins (Alcs) constitute a family of neuronal type I membrane proteins, designated Alc(alpha), Alc(beta), and Alc(gamma). The Alcs express in neurons dominantly and largely colocalize with the Alzheimer amyloid precursor protein (APP) in the brain. Alcs and APP show an identical function as a cargo receptor of
kinesin
-1. Moreover, proteolytic processing of Alc proteins appears highly similar to that of APP. We found that APP alpha-secretases ADAM 10 and ADAM 17 primarily cleave Alc proteins and trigger the subsequent secondary intramembranous cleavage of Alc C-terminal fragments by a presenilin-dependent gamma-secretase complex, thereby generating "APP p3-like" and non-aggregative Alc peptides (p3-Alcs). We determined the complete amino acid sequence of p3-Alc(alpha), p3-Alc(beta), and p3-Alc(gamma), whose major species comprise 35, 37, and 31 amino acids, respectively, in human cerebrospinal fluid. We demonstrate here that variant p3-Alc C termini are modulated by FAD-linked
presenilin 1
mutations increasing minor beta-amyloid species Abeta42, and these mutations alter the level of minor p3-Alc species. However, the magnitudes of C-terminal alteration of p3-Alc(alpha), p3-Alc(beta), and p3-Alc(gamma) were not equivalent, suggesting that one type of gamma-secretase dysfunction does not appear in the phenotype equivalently in the cleavage of type I membrane proteins. Because these C-terminal alterations are detectable in human cerebrospinal fluid, the use of a substrate panel, including Alcs and APP, may be effective to detect gamma-secretase dysfunction in the prepathogenic state of Alzheimer disease subjects.
...
PMID:Alcadein cleavages by amyloid beta-precursor protein (APP) alpha- and gamma-secretases generate small peptides, p3-Alcs, indicating Alzheimer disease-related gamma-secretase dysfunction. 1986 13